Main > ONCOLOGY (**) > Multiple Myeloma*** > Treatment > Co: USA. T. Bortezomib for Inj. B *

---

Co: USA. T. Bortezomib for Inj. B *'s subsections
(*) EU Approval Date: 2012. 09.28
(*) USA Approval Date: 2008. 06.20
Company
Mechanism: Proteasome Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2006. 03.14.
TradeMark
TradeMark Web-Site

Co: USA. T. Bortezomib for Inj. B *'s products
This section has no products